1. Introduction {#sec1}
===============

Ulcerative colitis (UC) is a chronic and progressive immunologically mediated disease causing consecutive mucosal inflammation of the colon \[[@B1], [@B2]\]. The onset of UC is most often during young adulthood, which is well characterized by homogeneous and continuous lesions \[[@B3]\]. Although the incidence of UC is increasing in Asia, it is highly diagnosed in the developed countries, especially in Western Europe and North America. Previous reports showed that the overall incidence and prevalence of UC are nearly 1.2/20.3 cases and 7.6/245 per 100,000 persons per year, respectively \[[@B4], [@B5]\].

UC therapy is aimed to reduce the recurrent rate, as well as improve the life quality and minimize drug-related adverse events. Basic therapies for UC are determined based on the severity of symptoms, which are often thought as step-up approaches. To date, 5-aminosalycilates (5-ASAs) have been the mainstay for treatment of mild-to-moderate UC \[[@B6]\]. Though 5-ASAs are safe and have no dose-related toxicity in short-term use with a dose-response efficacy, long-term use of them might induces adverse events, such as headache, diarrhea, nausea, interstitial nephritis, and hepatitis. In addition, patients with more moderate-to-severe UC after 5-ASAs therapy are typically treated with corticosteroids, and these patients are often followed by transition to a steroid-sparing agent with a thiopurine, adhesion molecule inhibitor, or anti-tumor necrosis factor (TNF) agent \[[@B6]\]. However, these corticosteroid-based therapies also accompany with side effects, such as cataracts, osteopenia, avascular necrosis, insomnia, mood changes, delirium, glaucoma, and adrenal insufficiency \[[@B7], [@B8]\]. Besides, despite improved medical therapies, it is estimated that about 15% of UC patients still require proctocolectomy \[[@B9]\]. Therefore, it is of great significance to develop more optimized and integrated therapies for UC patients.

To date, an increasing number of traditional Chinese herbal compounds are successfully used for treating UC with less side effects, such as Gegen Qinlian decoction \[[@B10]\], Jianpi Qingchang decoction \[[@B11], [@B12]\], Zhikang capsule \[[@B13]\], Huangkui Lianchang decoction \[[@B14]\], and Qingchang Wenzhong decoction \[[@B15], [@B16]\]. Quyushengxin formula is mainly composed of four herbs, *Panax ginseng* C.A. Mey. (Araliaceae), *Astragalus membranaceus* (Fisch) Bunge, *Pulsatilla chinensis* (Bge.) Regel, and *Coptis chinensis* Franch. Our clinical practice demonstrated Quyushengxin formula could relieve the clinical symptoms in active stage and suppress the inflammatory reaction of UC patients and could be used for treating mild-to-moderate UC \[[@B17]\]. Although the therapeutic effects of Quyushengxin on UC are attractive, molecular mechanisms of its action remain to be further elucidated.

Traditional Chinese medicine- (TCM-) oriented network pharmacology provides us a novel way to unveil the molecular mechanisms of TCM through pharmacokinetic evaluation, network/pathway analysis, and target prediction \[[@B18], [@B19]\]. In this study, we tried to unveil the molecular mechanisms of Quyushengxin formula acting on UC based on network pharmacology.

2. Materials and Methods {#sec2}
========================

2.1. Screening of Potential Bioactive Compounds in Quyushengxin Formula {#sec2.1}
-----------------------------------------------------------------------

Traditional Chinese Medicine Systems Pharmacology Database (TCMSP, <http://lsp.nwu.edu.cn>) is a systems pharmacology platform of Chinese herbal medicines that captures the relationships between drugs, targets, and diseases \[[@B20]\]. Ingredients along with their molecular weight (MW), water partition coefficient (AlogP), number of hydrogen bond donors (Hodn), number of hydrogen acceptors (Hacc), oral bioavailability (OB), Caco-2 permeability (Caco-2), blood-brain barrier (BBB), drug-likeness (DL), fractional negative accessible surface area (FASA) ,and half-life (HL), of all four herbs in Quyushengxin formula were retrieved from TCMSP. Then, absorption, distribution, metabolism, and excretion (ADME) properties, including OB, DL, and HL, were evaluated for screening out bioactive compounds. The potential bioactive compounds in Quyushengxin were predicted and sifted out via an integrated model including PreOB (for prediction of OL), PreDL (for prediction of DL), and PreHL (for prediction of HL) \[[@B21], [@B22]\]. In detail, OB value was obtained by OBioavail 1.1, and the compounds with OB ≥ 30% were selected out for further analysis \[[@B20], [@B23]\]. PreDL was utilized to calculate the DL index of compounds, and compounds with DL ≥ 0.18 were included for further research. The DL evaluation approach was constructed via both Tanimoto coefficient and molecular descriptors, and the formula is listed as follows:$$\begin{matrix}
{T\left( {X,Y} \right) = \frac{X \cdot Y}{\left| X \right|^{2} + \left| Y \right|^{2} - X \cdot Y},} \\
\end{matrix}$$where *X* was the molecular descriptors of herbal ingredients and *Y* showed the average molecular properties of all molecules in the DrugBank database (<http://www.drugbank.ca/>).

Besides, PreHL was estimated by combining multivariable linear regression model and MLR (mixed logistic regression) algorithm \[[@B22]\], as follows:$$\begin{matrix}
{Y\left( t_{1/2} \right) = 13.310\left( {\pm 13.31} \right) + 13.376\left( {\pm 13.37} \right) \times \text{nArCO}} \\
{+ 7.092\left( {\pm \text{nA}7} \right) \times \text{H}7\text{m} + 0.053\left( {\pm 0.007} \right) \times \left( {\text{D}/\text{Dr}09} \right) + 19.377\left( {\pm 4.052} \right)} \\
{\times N - 070 - 7.598\left( {\pm 70 - 7.} \right) \times C - 033 - 347.423\left( {\pm 33 - 347.} \right)} \\
{\times \text{JGI}6 + 32.752\left( {\pm \text{JG}2} \right) \times \text{nRC} = N - 0.100\left( {\pm \text{nR0}} \right) \times \text{Mor}02\text{e},} \\
{R^{2} = 0.65,} \\
{Q^{2} = 0.62,} \\
{F = 27.272,} \\
{\text{SEE} = 8.127,} \\
{N_{\text{training}} = 126,} \\
{N_{\text{test}} = 43,} \\
\end{matrix}$$where *R*^2^ was the correlation coefficient of training set and *Q*^2^ was the correlation coefficient of external test sets of the model. SEE was the estimated standard deviation of training set. *F* was the mean square ratio. Besides, *N*~training~ indicated the number of chemical compounds in the training set, and *N*~test~ indicated the number of chemical compounds in the test set. It was evidenced that there were eight descriptors satisfying the linear regression as follows: nArCO, H7m, D/Dr09, N-070, C-032, JGI6, nRC=N, and Mor02e. Finally, 4 ≤ HL ≤ 8 was defined as appropriate selection criteria for drug HL evaluation.

2.2. Prediction of the Candidate Targets of Bioactive Compounds {#sec2.2}
---------------------------------------------------------------

Weighted ensemble similarity (WES) algorithm was applied for predicting direct targets of the bioactive compounds via a large scale of drug target relationships \[[@B24]\]. Those targets with likelihood score ≥7 were deemed as direct targets in this study. Thereafter, candidate targets were mapped to Uniprot (<http://www.uniprot.org/>) for annotation and normalization.

2.3. Functional Enrichment Analyses {#sec2.3}
-----------------------------------

Gene Ontology- (GO-) biological processes (BPs) and Kyoto Encyclopedia of Genes and Genomes (KEGG, <http://www.genome.jp/kegg/>) pathways of the candidate targets of bioactive compounds were predicted via the Database for Annotation, Visualization, and Integrated Discovery (DAVID) database \[[@B25]\] with *P* \< 0.05 as the criterion for significance.

2.4. Prediction of Target-Related Disease {#sec2.4}
-----------------------------------------

Target-related diseases were predicted by integrating multisource databases, including Comparative Toxicogenomics Database (CTD, <http://ctdbase.org/>) \[[@B26]\], Therapeutic Target Database (TTD, <http://bidd.nus.edu.sg/group/cjttd/>) \[[@B27]\], and PharmGKB database (<https://www.pharmgkb.org/>) \[[@B28]\].

2.5. Network Construction {#sec2.5}
-------------------------

Three kinds of networks in this study were established using Cytoscape 3.6.0 software \[[@B29]\]: compound-target network (C-T network), target-disease network (T-D network), and target-pathway network (T-P network). C-T network was composed of bioactive compounds and their potential targets, which was built to reveal the drug-target interactions. T-D network was built based on the potential targets and their related diseases. The pathway information of targets was selected from the results for KEGG pathway enrichment analysis by excluding those pathways with no relevance to UC based the latest pathological information of UC. T-P network was generated based on potential targets and UC-related pathways. In the networks, the nodes represented compounds, targets, diseases, and pathways, and the edges displayed the interactions between two nodes. Furthermore, the significance of each node in the networks was assessed via one crucial topological parameter, namely, "degree," which was defined as the total of edges related with a node \[[@B30], [@B31]\]. Degree of all nodes was analyzed using plugin NetworkAnalyzer of Cytoscape 3.6.0.

3. Results {#sec3}
==========

3.1. Screening of Potential Bioactive Compounds from Four Herbs in Quyushengxin Formula {#sec3.1}
---------------------------------------------------------------------------------------

Quyushengxin formula consists of 4 main herbs: *Panax ginseng* C.A. Mey. (Araliaceae), *Astragalus membranaceus* (Fisch) Bunge, *Pulsatilla chinensis* (Bge.) Regel, and *Coptis chinensis* Franch. After retrieving from TCMSP, 190, 87, 57, and 48 ingredients were obtained for these four herbs, respectively. Based on the criteria of OB ≥ 30%, DL ≥ 0.18, and 4 ≤ HL ≤ 8, 41 potential bioactive compounds, including quercetin, ursolic acid, kaempferol, *β*-sitosterol, and rutin, were sifted out ([Table 1](#tab1){ref-type="table"}), which accounted for 10.73% of all 382 ingredients in Quyushengxin.

3.2. Establishment of C-T Network {#sec3.2}
---------------------------------

Candidate targets of the 41 bioactive compounds were predicted via WES algorithm. A total of 367 potential targets for these 41 bioactive compounds were obtained. After removing the overlapping targets, 94 candidate proteins were reserved. Then, C-T network was built by Cytoscape 3.6.0 which contains 367 connections between 41 compounds and corresponding 94 candidate targets ([Figure 1](#fig1){ref-type="fig"}). The degrees of the 41 bioactive compounds in the C-T network were calculated and are displayed in [Table 1](#tab1){ref-type="table"}. The average degree of targets per compound was 4.7, indicating multitarget functions of Quyushengxin formula. Among the 41 bioactive compounds, 8 of them showed a high degree (degree \> 10). Quercetin possessed the highest degree of targets (degree = 73), followed by ursolic acid (degree = 35), kaempferol (degree = 26), *β*-sitosterol (degree = 15), rutin (degree = 15), 7-O-methylisomucronulatol (degree = 11), stigmasterol (degree = 10), and isorhamnetin (degree = 10).

The degree of the candidate targets was also calculated and displayed in [Table 2](#tab2){ref-type="table"}. Eight out of the 94 compounds possessed a degree larger than 10, including ESR1 (estrogen receptor 1, degree = 34), PTGS2 (prostaglandin-endoperoxide synthase 2, degree = 27), NOS2 (nitric oxide synthase 2, degree = 25), PTGS1 (degree = 23), PPARG (peroxisome proliferator-activated receptor gamma, degree = 21), NOS3 (degree = 21), ESR2 (degree = 17), and KCNH2 (Potassium Voltage-Gated Channel Subfamily H Member 2, degree = 13).

3.3. GO-BP Analysis {#sec3.3}
-------------------

To further validate whether biological processes enriched by candidate targets as mentioned above were correlated with UC, GO-BP enrichment analysis was performed via DAVID. The top 20 significant GO-BP terms are shown in [Figure 2](#fig2){ref-type="fig"}. Most of them were strongly associated with inflammatory- and immune-related BPs such as "positive regulation of interleukin-6 biosynthetic process," "regulation of inflammatory response," "immune response," and "positive regulation of T-cell proliferation." In short, the 41 bioactive compounds in Quyushengxin formula may act on 94 candidate targets with inflammatory- and immune-related effects to affect UC pathogenesis.

3.4. Establishment of T-D Network {#sec3.4}
---------------------------------

Target-related diseases were predicted by mapping them to integrating multisource databases, including CTD, TTD, and PharmGKB. A T-D network consisting of 90 targets and 4 kinds of diseases was built ([Figure 3](#fig3){ref-type="fig"}). The four diseases were digestive system disease (degree = 60), pathology (degree = 49), cancer (degree = 23), and signs and symptoms (degree = 14).

3.5. T-P Network Evaluation {#sec3.5}
---------------------------

KEGG pathway enrichment analysis was performed for the 94 targets, and T-P network was built. Results displayed that 79 targets could be further mapped to 78 pathways, including "mTOR signaling pathway," "T-cell receptor signaling pathway," "JAK-STAT signaling pathway," and "FOXO signaling pathway" ([Figure 4](#fig4){ref-type="fig"}). The average degree of targets was 6.85, and the average degree of pathway was 2.8. In addition, 71 candidate targets could be mapped to several pathways (≥5), suggesting that these targets might mediate the cross-talk and interactions between different pathways. Besides, those pathways (70/78) mapped by multiple targets (≥8) might be the main factors for UC development and progression. These pathways were further divided into five function modules, including inflammatory regulation, immune regulation, metabolic regulation, bacterial infection or mycosis and other function.

3.6. Establishment of Compound-Target-Function Module Network {#sec3.6}
-------------------------------------------------------------

By combing the networks above, a compound-target-function module network was built, which included 140 nodes (5 function modules, 41 compounds and 95 targets) and 653 edges ([Figure 5](#fig5){ref-type="fig"}).

3.7. Details of 4 UC-Related Pathways from T-P Network Analysis {#sec3.7}
---------------------------------------------------------------

To further unveil the multi-targets mechanisms of Quyushengxin formula in the treatment of UC, an integrated "UC-related pathway" was established according to the key pathways from the T-P network analysis. UC-related pathways as shown in [Figure 6](#fig6){ref-type="fig"} were composed of four pathways, including "T cell receptor signaling pathway" (hsa04660), "FOXO signaling pathway" (hsa04068), "JAK-STAT signaling pathway" (hsa04630) and "mTOR signaling pathway" (hsa04150). Those targets of the integrated "UC-related pathways" displayed the functional relationship with the UC-related proteins. UC-related pathways can be divided into three modules: immunology module, metabolism module and cell apoptosis-related module. Immunology module consisted of "T cell receptor signaling pathway" (hsa04660), and metabolism module consisted of "FOXO signaling pathway" (hsa04068). Cell apoptosis-related module was comprised of "JAK-STAT signaling pathway" (hsa04630) and "mTOR signaling pathway" (hsa04150). Taken together, Quyushengxin formula may well regulate immunology progress, metabolism progress and cell apoptosis progress to suppress UC progression.

4. Discussion {#sec4}
=============

TCM has the advantages of high treatment efficacy and low treatment cost and side effect in the treatment of several diseases, including UC in China for several thousands of years \[[@B32]--[@B34]\]. After preliminary screening based on ADME properties, 41 potential bioactive compounds of Quyushengxin were screened out. Thereafter, 94 candidate targets of these 41 bioactive compounds were predicted for further analysis. Functional enrichment analyses suggested that these targets were closely related with inflammatory- and immune-related biological processes. Besides, a C-T network, a T-D network, a T-P network, and a compound-target-function module network were built. These networks indicated that the therapeutic effects of Quyushengxin on UC may be achieved through the synergistic and additive effects on multiple molecules and multiple pathways with immune and inflammatory effects to treat UC.

Previous reports showed that the TCMSP-based method was reliable for screening out bioactive compounds of TCM for treatment of thrombosis \[[@B35]\], gastric precancerous lesions \[[@B36]\], cardiocerebrovascular disease \[[@B37]\], and rheumatoid arthritis \[[@B38]\]. In this study, 41 bioactive compounds of Quyushengxin formula were selected out by using TCMSP database in combination with ADME properties. Most of the 41 compounds have been reported to have anti-inflammatory and immune-regulatory effects. For example, quercetin (mol01, OB = 46.43%, DL = 0.28, HL = 14.40) could inhibit lipopolysaccharide- (LPS-) induced interleukin- (IL-) 6 production \[[@B39]\], TNF-*α* production, and IL-8 production \[[@B40], [@B41]\] to exert anti-inflammatory effect. Besides, ursolic acid (mol17, OB = 16.77%, DL = 0.75, HL = 5.28) was reported to have human neutrophil elastase inhibitory effect both *in vitro* and *in vivo* \[[@B42]\]. Kaempferol (mol17, OB = 41.88%, DL = 0.24, HL = 14.74) was reported to significantly reduce the overproduction of TNF-*α*, IL-1*β*, IL-6, intercellular adhesion molecule- (ICAM-) 1, and vascular cell adhesion molecule- (VCAM-) 1 induced by LPS \[[@B43]\]. In addition, *β*-sitosterol (mol16, OB = 36.91%, DL = 0.75, HL = 5.36) and rutin (mol33, OB = 3.2%, DL = 0.68, HL = 6.22) were shared with significant anti-inflammatory activity \[[@B44], [@B45]\]. Above all, TCMSP-based systems pharmacology sifted out 41 potential bioactive compounds in Quyushengxin formula for treatment of UC.

Eight of the 94 targets have degree larger than 10 in the C-T network, including ESR1, PTGS2, NOS2, PTGS1, PPARG, NOS3, ESR2, and KCNH2. ESR1 was targeted by 34 compounds, which contributed to T-cell-mediated autoimmune inflammation by promoting T-cell activation and proliferation \[[@B46]\]. Besides, PTGS2 with the second highest degree played a critical role in the pathogenesis of gut inflammation \[[@B47], [@B48]\]. Moreover, PPARG was demonstrated to be able to downregulate proinflammatory cytokines production, such as IL-4, -5, and -6. In addition, PPARG could also enable to interfere with profibrotic molecules, such as platelet-derived growth factor (PDGF), IL-1, and transforming growth factor beta (TGF-*β*) \[[@B49]\]. These results suggested that Quyushengxin formula could probably treat UC by regulating anti-inflammatory action and the immune system.

In this study, 94 targets were utilized to perform T-P network analysis, and the results showed that 79 targets could be further mapped to 78 pathways. Meanwhile, numerous pathways mapped by multiple targets might be the main factors for UC progression. Four pathways including "T-cell receptor signaling pathway," "FOXO signaling pathway," "JAK-STAT signaling pathway," and "mTOR signaling pathway" were closely associated with immune and inflammatory effects. T-cell receptors play significant role in function of T cells and formation of the immunological synapse, and they connected T cells and the antigen-presenting cells \[[@B50]\]. T-cell receptor pathway was reported to be important in regulation of UC \[[@B51], [@B52]\]. FOXO pathway plays a key role in regulating the expression of genes related to cell function such as apoptosis, cell cycle, oxidative stress, and differentiation \[[@B53]--[@B55]\]. FOXO3a was shown to control the inflammatory response and help maintain the homeostasis of the intestinal mucosa, which may also be a protective factor in the gut, and maintain a balance between the mucosal immune hemostasis against intravascular bacteria and inflammatory cytokines \[[@B56]\]. Besides, JAK-STAT pathway is the fulcrum for many important cellular processes, including cell survival, differentiation, proliferation, and regulation of immune function \[[@B57]\]. The mTOR pathway plays an important role in regulation of cell metabolism, proliferation, and autophagy. It is reported that mTOR signaling pathway was activated in bacteria-induced colitis in mice \[[@B58]\]. Inhibitors of mTOR signaling pathway are effective as anti-inflammatory drugs in treating colitis \[[@B59]--[@B61]\]. Therefore, Quyushengxin might suppress UC progression through targeting these anti-inflammation, autophagy, and immunoregulation pathways.

Nevertheless, limitations in this study could never be neglected. First, results in this study were mainly based on known chemical components in Quyushengxin, related targets, and pathways in UC. With the development of science and technology, new components in Quyushengxin, as well as new targets and pathways in UC will be further discovered, which will supply us with more theoretical evidences for further elucidation of underlying mechanisms of UC pathology. Second, the interaction relationships of the nodes in the networks, such as the action type, e.g., activation, inhibition, binding, and catalysis, and the action effect, e.g., positive, negative, and unspecified, are not investigated due to lack of these data. Third, due to the complex interaction between TCM and the human body, many of its acting mechanisms still needed to be further elucidated via pharmacokinetic test and other experiments.

5. Conclusion {#sec5}
=============

In short, network pharmacology analysis of Quyushengxin showed that 41 bioactive components of Quyushengxin may act on 94 immune and inflammation-related targets to suppress UC progression in a synergistic and additive manner, which may provide us with a new starting point for a more detailed knowledge of mechanisms of UC pathogenesis.
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![Compound-target network. A compound node and a target node are connected.](ECAM2019-7870424.001){#fig1}

![Gene Ontology biological process analysis. The *y*-axis shows significantly enriched "Biological Processes" categories, and the *x*-axis shows the enrichment scores of these terms.](ECAM2019-7870424.002){#fig2}

![Target-disease network. Red square represents disease and green circle represents target.](ECAM2019-7870424.003){#fig3}

![Target-pathway network. Red square represents pathway and purple circle represents targets.](ECAM2019-7870424.004){#fig4}

![Compound-target-function module network. Green circle represents compound, blue square represents target, and red hexagon represents function module.](ECAM2019-7870424.005){#fig5}

![Distribution of targets of Quyushengxin formula in the "UC-related pathway." Arrow shows activation effect; T-shaped arrow shows inhibition effect, and dotted arrow represents indirect activation effect or inhibition effect.](ECAM2019-7870424.006){#fig6}

###### 

Details of 41 bioactive compounds and their biological parameters.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ID      Compounds                                                                                                                    Structure                             OB (%)   DL     HL      Degree   Herb
  ------- ---------------------------------------------------------------------------------------------------------------------------- ------------------------------------- -------- ------ ------- -------- --------------------------------------------
  mol01   Quercetin                                                                                                                    ![](ECAM2019-7870424.tab1.i001.jpg)   46.43    0.28   14.40   73       *Coptis chinensis* Franch\
                                                                                                                                                                                                              *Astragalus membranaceus* (Fisch) Bunge

                                                                                                                                                                                                              

  mol02   Ferulic acid                                                                                                                 ![](ECAM2019-7870424.tab1.i002.jpg)   39.56    0.06   2.38    7        *Coptis chinensis* Franch

                                                                                                                                                                                                              

  mol03   Palmatine                                                                                                                    ![](ECAM2019-7870424.tab1.i003.jpg)   64.60    0.65   2.25    9        *Coptis chinensis* Franch

                                                                                                                                                                                                              

  mol04   Jatrorrizine                                                                                                                 ![](ECAM2019-7870424.tab1.i004.jpg)   19.65    0.59   4.21    9        *Coptis chinensis* Franch

                                                                                                                                                                                                              

  mol05   Berberine                                                                                                                    ![](ECAM2019-7870424.tab1.i005.jpg)   36.86    0.78   6.57    8        *Coptis chinensis* Franch

  mol06   Columbamine                                                                                                                  ![](ECAM2019-7870424.tab1.i006.jpg)   26.94    0.59   5.21    9        *Coptis chinensis* Franch

                                                                                                                                                                                                              

  mol07   Coptisine                                                                                                                    ![](ECAM2019-7870424.tab1.i007.jpg)   30.67    0.86   9.33    8        *Coptis chinensis* Franch

                                                                                                                                                                                                              

  mol08   Worenine                                                                                                                     ![](ECAM2019-7870424.tab1.i008.jpg)   45.83    0.87   8.41    6        *Coptis chinensis* Franch

                                                                                                                                                                                                              

  mol09   Magnoflorine                                                                                                                 ![](ECAM2019-7870424.tab1.i009.jpg)   0.48     0.55   6.22    8        *Coptis chinensis* Franch

                                                                                                                                                                                                              

  mol10   Berberrubine                                                                                                                 ![](ECAM2019-7870424.tab1.i010.jpg)   35.74    0.73   6.46    8        *Coptis chinensis* Franch

  mol11   Epiberberine                                                                                                                 ![](ECAM2019-7870424.tab1.i011.jpg)   43.09    0.78   6.10    7        *Coptis chinensis* Franch

                                                                                                                                                                                                              

  mol12   (*R*)-Canadine                                                                                                               ![](ECAM2019-7870424.tab1.i012.jpg)   55.37    0.77   6.41    9        *Coptis chinensis* Franch

                                                                                                                                                                                                              

  mol13   Berlambine                                                                                                                   ![](ECAM2019-7870424.tab1.i013.jpg)   36.68    0.82   7.33    9        *Coptis chinensis* Franch

                                                                                                                                                                                                              

  mol14   Corchoroside A_qt                                                                                                            ![](ECAM2019-7870424.tab1.i014.jpg)   104.95   0.78   6.68    2        *Coptis chinensis* Franch

  mol15   Tetrandrine                                                                                                                  ![](ECAM2019-7870424.tab1.i015.jpg)   26.64    0.10   4.77    9        *Coptis chinensis* Franch

                                                                                                                                                                                                              

  mol16   *β*-Sitosterol                                                                                                               ![](ECAM2019-7870424.tab1.i016.jpg)   36.91    0.75   5.36    15       *Panax ginseng* C.A. Mey. (Araliaceae)\
                                                                                                                                                                                                              *Pulsatilla chinensis* (Bge.) Regel

                                                                                                                                                                                                              

  mol17   Kaempferol                                                                                                                   ![](ECAM2019-7870424.tab1.i017.jpg)   41.88    0.24   14.74   26       *Panax ginseng* C.A. Mey. (Araliaceae)

                                                                                                                                                                                                              

  mol18   Stigmasterol                                                                                                                 ![](ECAM2019-7870424.tab1.i018.jpg)   43.83    0.76   5.57    10       *Panax ginseng C.A. Mey*. (*Araliaceae*)G\
                                                                                                                                                                                                              *Pulsatilla chinensis* (Bge.) Regel

                                                                                                                                                                                                              

  mol19   *β*-Elemene                                                                                                                  ![](ECAM2019-7870424.tab1.i019.jpg)   25.63    0.06   6.32    8        *Panax ginseng* C.A. Mey. (Araliaceae)

  mol20   Ginsenoside Ro_qt                                                                                                            ![](ECAM2019-7870424.tab1.i020.jpg)   17.62    0.76   7.50    1        *Panax ginseng* C.A. Mey. (Araliaceae)

                                                                                                                                                                                                              

  mol21   Dianthramine                                                                                                                 ![](ECAM2019-7870424.tab1.i021.jpg)   40.45    0.20   5.14    3        *Panax ginseng* C.A. Mey. (Araliaceae)

                                                                                                                                                                                                              

  mol22   Arachidonate                                                                                                                 ![](ECAM2019-7870424.tab1.i022.jpg)   45.57    0.20   7.56    5        *Panax ginseng* C.A. Mey. (Araliaceae)

                                                                                                                                                                                                              

  mol23   Ginsenoside La_qt                                                                                                            ![](ECAM2019-7870424.tab1.i023.jpg)   15.70    0.78   5.20    1        *Panax ginseng* C.A. Mey. (Araliaceae)

  mol24   Ginsenoside rh2                                                                                                              ![](ECAM2019-7870424.tab1.i024.jpg)   36.32    0.56   11.08   9        *Panax ginseng* C.A. Mey. (Araliaceae)

                                                                                                                                                                                                              

  mol25   Ginsenoside-Rh3_qt                                                                                                           ![](ECAM2019-7870424.tab1.i025.jpg)   13.09    0.76   6.22    1        *Panax ginseng* C.A. Mey. (Araliaceae)

                                                                                                                                                                                                              

  mol26   Ginsenoside-Rh4_qt                                                                                                           ![](ECAM2019-7870424.tab1.i026.jpg)   31.11    0.78   6.97    1        *Panax ginseng* C.A. Mey. (Araliaceae)

                                                                                                                                                                                                              

  mol27   Malkangunin                                                                                                                  ![](ECAM2019-7870424.tab1.i027.jpg)   57.71    0.63   4.09    1        *Panax ginseng* C.A. Mey. (Araliaceae)

  mol28   Alexandrin_qt                                                                                                                ![](ECAM2019-7870424.tab1.i028.jpg)   36.91    0.75   5.53    1        *Panax ginseng* C.A. Mey. (Araliaceae)

                                                                                                                                                                                                              

  mol29   Ginsenoside rf                                                                                                               ![](ECAM2019-7870424.tab1.i029.jpg)   17.74    0.24   4.66    5        *Panax ginseng* C.A. Mey. (Araliaceae)

                                                                                                                                                                                                              

  mol30   Hederagenin                                                                                                                  ![](ECAM2019-7870424.tab1.i030.jpg)   36.91    0.75   5.35    6        *Astragalus membranaceus* (Fisch) Bunge

                                                                                                                                                                                                              

  mol31   Isorhamnetin                                                                                                                 ![](ECAM2019-7870424.tab1.i031.jpg)   49.60    0.31   14.34   10       *Astragalus membranaceus* (Fisch) Bunge\
                                                                                                                                                                                                              *Pulsatilla chinensis* (Bge.) Regel

  mol32   7-O-methylisomucronulatol                                                                                                    ![](ECAM2019-7870424.tab1.i032.jpg)   74.69    0.30   2.98    11       *Astragalus membranaceus* (Fisch) Bunge

                                                                                                                                                                                                              

  mol33   Rutin                                                                                                                        ![](ECAM2019-7870424.tab1.i033.jpg)   3.20     0.68   6.22    15       *Astragalus membranaceus* (Fisch) Bunge

                                                                                                                                                                                                              

  mol34   1,7-Dihydroxy-3,9-dimethoxy pterocarpene                                                                                     ![](ECAM2019-7870424.tab1.i034.jpg)   39.05    0.48   7.95    5        *Astragalus membranaceus* (Fisch) Bunge

                                                                                                                                                                                                              

  mol35   Isoferulic acid                                                                                                              ![](ECAM2019-7870424.tab1.i035.jpg)   50.83    0.06   2.45    7        *Astragalus membranaceus* (Fisch) Bunge

  mol36   Betulinic acid                                                                                                               ![](ECAM2019-7870424.tab1.i036.jpg)   55.38    0.78   8.87    1        *Pulsatilla chinensis* (Bge.) Regel

                                                                                                                                                                                                              

  mol37   Oleanolic acid                                                                                                               ![](ECAM2019-7870424.tab1.i037.jpg)   29.02    0.76   5.56    6        *Pulsatilla chinensis* (Bge.) Regel

                                                                                                                                                                                                              

  mol38   Sitosteryl acetate                                                                                                           ![](ECAM2019-7870424.tab1.i038.jpg)   40.39    0.85   6.34    1        *Pulsatilla chinensis* (Bge.) Regel

                                                                                                                                                                                                              

  mol39   Lanosterol                                                                                                                   ![](ECAM2019-7870424.tab1.i039.jpg)   42.12    0.75   5.84    1        *Pulsatilla chinensis* (Bge.) Regel

  mol40   3-beta,23-Dihydroxy-lup-20(29)-ene-28-O-alpha-L-rhamnopyranosyl-(1-4)-beta-D-glucopyranosyl(1-6)-beta-D-glucopyranoside_qt   ![](ECAM2019-7870424.tab1.i040.jpg)   37.59    0.79   6.70    1        *Pulsatilla chinensis* (Bge.) Regel

                                                                                                                                                                                                              

  mol41   Ursolic acid                                                                                                                 ![](ECAM2019-7870424.tab1.i041.jpg)   16.77    0.75   5.28    35       *Pulsatilla chinensis* (Bge.) Regel
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Details of 94 UC-related targets of herbs via UniProt.

  ID   UniProt                                            Protein names                                                                                          Gene names   Degree   Organism
  ---- -------------------------------------------------- ------------------------------------------------------------------------------------------------------ ------------ -------- ------------------------------------------------------
  1    P35228                                             Nitric oxide synthase, inducible                                                                       NOS2         25       [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  2    [P23219](https://www.uniprot.org/uniprot/P23219)   Prostaglandin G/H synthase 1                                                                           PTGS1        23       [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  3    [P03372](https://www.uniprot.org/uniprot/P03372)   Estrogen receptor                                                                                      ESR1         34       [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  4    [P37231](https://www.uniprot.org/uniprot/P37231)   Peroxisome proliferator-activated receptor gamma                                                       PPARG        21       [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  5    P35354                                             Prostaglandin G/H synthase 2                                                                           PTGS2        27       [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  6    [Q92731](https://www.uniprot.org/uniprot/Q92731)   Estrogen receptor beta                                                                                 ESR2         17       [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  7    [P11388](https://www.uniprot.org/uniprot/P11388)   DNA topoisomerase 2-alpha                                                                              TOP2A        5        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  8    [P16389](https://www.uniprot.org/uniprot/P16389)   Potassium voltage-gated channel subfamily H member 2                                                   KCNH2        13       [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  9    [P08709](https://www.uniprot.org/uniprot/P08709)   Coagulation factor VII                                                                                 F7           6        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  10   [P29474](https://www.uniprot.org/uniprot/P29474)   Nitric-oxide synthase, endothelial                                                                     NOS3         21       [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  11   [P27338](https://www.uniprot.org/uniprot/P27338)   Amine oxidase \[flavin-containing\] B                                                                  MAOB         5        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  12   [Q04206](https://www.uniprot.org/uniprot/Q04206)   Transcription factor p65                                                                               RELA         6        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  13   [P00533](https://www.uniprot.org/uniprot/P00533)   Epidermal growth factor receptor                                                                       EGFR         1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  14   [P31749](https://www.uniprot.org/uniprot/P31749)   RAC-alpha serine/threonine-protein kinase                                                              AKT1         2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  15   [P15692](https://www.uniprot.org/uniprot/P15692)   Vascular endothelial growth factor A                                                                   VEGFA        2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  16   [P24385](https://www.uniprot.org/uniprot/P24385)   G1/S-specific cyclin-D1                                                                                CCND1        3        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  17   [P10415](https://www.uniprot.org/uniprot/P10415)   Apoptosis regulator Bcl-2                                                                              BCL2         5        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  18   [P01100](https://www.uniprot.org/uniprot/P01100)   Proto-oncogene c-Fos                                                                                   FOS          3        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  19   [P38936](https://www.uniprot.org/uniprot/P38936)   Cyclin-dependent kinase inhibitor 1                                                                    CDKN1A       4        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  20   [P55211](https://www.uniprot.org/uniprot/P55211)   Caspase-9                                                                                              CASP9        4        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  21   [P00749](https://www.uniprot.org/uniprot/P00749)   Urokinase-type plasminogen activator                                                                   PLAU         4        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  22   [P08253](https://www.uniprot.org/uniprot/P08253)   72 kDa type IV collagenase                                                                             MMP2         2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  23   [P14780](https://www.uniprot.org/uniprot/P14780)   Matrix metalloproteinase-9                                                                             MMP9         2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  24   [P22301](https://www.uniprot.org/uniprot/P22301)   Interleukin-10                                                                                         IL10         1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  25   [P01133](https://www.uniprot.org/uniprot/P01133)   Proepidermal growth factor                                                                             EGF          1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  26   [P06400](https://www.uniprot.org/uniprot/P06400)   Retinoblastoma-associated protein                                                                      RB1          2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  27   [P01375](https://www.uniprot.org/uniprot/P01375)   Tumor necrosis factor                                                                                  TNF          6        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  28   [P05412](https://www.uniprot.org/uniprot/P05412)   Transcription factor AP-1                                                                              JUN          4        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  29   [P05231](https://www.uniprot.org/uniprot/P05231)   Interleukin-6                                                                                          IL-6         3        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  30   [P42574](https://www.uniprot.org/uniprot/P42574)   Caspase-3                                                                                              CASP3        7        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  31   [P04637](https://www.uniprot.org/uniprot/P04637)   Cellular tumor antigen p53                                                                             TP53         4        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  32   [P11926](https://www.uniprot.org/uniprot/P11926)   Ornithine decarboxylase                                                                                ODC1         1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  33   [Q14790](https://www.uniprot.org/uniprot/Q14790)   Caspase-8                                                                                              CASP8        3        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  34   [P00441](https://www.uniprot.org/uniprot/P00441)   Superoxide dismutase \[Cu-Zn\]                                                                         SOD1         2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  35   [P17252](https://www.uniprot.org/uniprot/P17252)   Protein kinase C alpha type                                                                            PRKCA        2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  36   [P03956](https://www.uniprot.org/uniprot/P03956)   Interstitial collagenase                                                                               MMP1         3        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  37   [P42224](https://www.uniprot.org/uniprot/P42224)   Signal transducer and activator of transcription 1-alpha/beta                                          STAT1        2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  38   [P04626](https://www.uniprot.org/uniprot/P04626)   Receptor tyrosine-protein kinase erbB-2                                                                ERBB2        1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  39   [P09601](https://www.uniprot.org/uniprot/P09601)   Heme oxygenase 1                                                                                       HMOX1        3        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  40   [P05177](https://www.uniprot.org/uniprot/P05177)   Cytochrome P450 1A2                                                                                    CYP1A2       2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  41   [P01106](https://www.uniprot.org/uniprot/P01106)   Myc proto-oncogene protein                                                                             MYC          1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  42   [P05362](https://www.uniprot.org/uniprot/P05362)   Intercellular adhesion molecule 1                                                                      ICAM1        4        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  43   [P01584](https://www.uniprot.org/uniprot/P01584)   Interleukin-1 beta                                                                                     IL1B         5        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  44   [P13500](https://www.uniprot.org/uniprot/P13500)   C-C motif chemokine 2                                                                                  CCL2         1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  45   [P19320](https://www.uniprot.org/uniprot/P19320)   Vascular cell adhesion protein 1                                                                       VCAM1        2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  46   [P10145](https://www.uniprot.org/uniprot/P10145)   Interleukin-8                                                                                          CXCL8        2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  47   [P05771](https://www.uniprot.org/uniprot/P05771)   Protein kinase C beta type                                                                             PRKCB        2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  48   [O15392](https://www.uniprot.org/uniprot/O15392)   Baculoviral IAP repeat-containing protein 5                                                            BIRC5        2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  49   [P04792](https://www.uniprot.org/uniprot/P04792)   Heat shock protein beta-1                                                                              HSPB1        1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  50   [P01137](https://www.uniprot.org/uniprot/P01137)   Transforming growth factor beta-1                                                                      TGFB1        3        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  51   [P60568](https://www.uniprot.org/uniprot/P60568)   Interleukin-2                                                                                          IL2          2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  52   [Q16678](https://www.uniprot.org/uniprot/Q16678)   Cytochrome P450 1B1                                                                                    CYP1B1       2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  53   [P00750](https://www.uniprot.org/uniprot/P00750)   Tissue-type plasminogen activator                                                                      PLAT         1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  54   [P01579](https://www.uniprot.org/uniprot/P01579)   Interferon gamma                                                                                       IFNG         4        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  55   [P09917](https://www.uniprot.org/uniprot/P09917)   Arachidonate 5-lipoxygenase                                                                            ALOX5        3        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  56   [P60484](https://www.uniprot.org/uniprot/P60484)   Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN   PTEN         1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  57   [P05164](https://www.uniprot.org/uniprot/P05164)   Myeloperoxidase                                                                                        MPO          1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  58   [Q9UNQ0](https://www.uniprot.org/uniprot/Q9UNQ0)   ATP-binding cassette subfamily G member 2                                                              ABCG2        1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  59   [P09211](https://www.uniprot.org/uniprot/P09211)   Glutathione S-transferase P                                                                            GSTP1        3        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  60   [Q16236](https://www.uniprot.org/uniprot/Q16236)   Nuclear factor erythroid 2-related factor 2                                                            NFE2L2       1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  61   [P15559](https://www.uniprot.org/uniprot/P15559)   NAD(P)H dehydrogenase \[quinone\] 1                                                                    NQO1         2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  62   [P09874](https://www.uniprot.org/uniprot/P09874)   Poly \[ADP-ribose\] polymerase 1                                                                       PARP1        1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  63   [P35869](https://www.uniprot.org/uniprot/P35869)   Aryl hydrocarbon receptor                                                                              AHR          2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  64   [P19875](https://www.uniprot.org/uniprot/P19875)   C-X-C motif chemokine 2                                                                                CXCL2        1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  65   [O96017](https://www.uniprot.org/uniprot/O96017)   Serine/threonine-protein kinase Chk2                                                                   CHEK2        1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  66   [Q07869](https://www.uniprot.org/uniprot/Q07869)   Peroxisome proliferator-activated receptor alpha                                                       PPARA        1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  67   [P02741](https://www.uniprot.org/uniprot/P02741)   C-reactive protein                                                                                     CRP          1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  68   [P02778](https://www.uniprot.org/uniprot/P02778)   C-X-C motif chemokine 10                                                                               CXCL10       1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  69   [Q9NS23](https://www.uniprot.org/uniprot/Q9NS23)   Ras association domain-containing protein 1                                                            RASSF1       1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  70   [P17936](https://www.uniprot.org/uniprot/P17936)   Insulin-like growth factor-binding protein 3                                                           IGFBP3       1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  71   [P01344](https://www.uniprot.org/uniprot/P01344)   Insulin-like growth factor II                                                                          IGF2         1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  72   [P21860](https://www.uniprot.org/uniprot/P21860)   Receptor tyrosine-protein kinase erbB-3                                                                ERBB3        1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  73   [P09488](https://www.uniprot.org/uniprot/P09488)   Glutathione S-transferase Mu 1                                                                         GSTM1        2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  74   [P28223](https://www.uniprot.org/uniprot/P28223)   5-Hydroxytryptamine 2A receptor                                                                        HTR2A        4        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  75   [P84022](https://www.uniprot.org/uniprot/P84022)   Mothers against decapentaplegic homolog 3                                                              SMAD3        1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  76   [P08588](https://www.uniprot.org/uniprot/P08588)   Beta-1 adrenergic receptor                                                                             ADRB1        3        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  77   [P29466](https://www.uniprot.org/uniprot/P29466)   Caspase-1                                                                                              CASP1        2        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  78   [P18509](https://www.uniprot.org/uniprot/P18509)   Pituitary adenylate cyclase-activating polypeptide                                                     ADCYAP1      1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  79   [O95456](https://www.uniprot.org/uniprot/O95456)   Proteasome assembly chaperone 1                                                                        PSMG1        1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  80   [P05112](https://www.uniprot.org/uniprot/P05112)   Interleukin-4                                                                                          IL-4         1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  81   [P00325](https://www.uniprot.org/uniprot/P00325)   Alcohol dehydrogenase 1B                                                                               ADH1B        1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  82   [P28702](https://www.uniprot.org/uniprot/P28702)   Retinoic acid receptor RXR-beta                                                                        RXRB         1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  83   [P04040](https://www.uniprot.org/uniprot/P04040)   Catalase                                                                                               CAT          1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  84   [P01308](https://www.uniprot.org/uniprot/P01308)   Insulin                                                                                                INS          1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  85   [P21731](https://www.uniprot.org/uniprot/P21731)   Thromboxane A2 receptor                                                                                TBXA2R       1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  86   [P07858](https://www.uniprot.org/uniprot/P07858)   Cathepsin B                                                                                            CTSB         1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  87   [P40763](https://www.uniprot.org/uniprot/P40763)   Signal transducer and activator of transcription 3                                                     STAT3        1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  88   [Q00534](https://www.uniprot.org/uniprot/Q00534)   Cell division protein kinase 6                                                                         CDK6         1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  89   [P09038](https://www.uniprot.org/uniprot/P09038)   Heparin-binding growth factor 2                                                                        FGF2         1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  90   [P15336](https://www.uniprot.org/uniprot/P15336)   Cyclic AMP-dependent transcription factor ATF-2                                                        ATF2         1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  91   [P04141](https://www.uniprot.org/uniprot/P04141)   Granulocyte-macrophage colony-stimulating factor                                                       CSF2         1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  92   [P17677](https://www.uniprot.org/uniprot/P17677)   Neuromodulin                                                                                           GAP43        1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  93   [P18031](https://www.uniprot.org/uniprot/P18031)   Tyrosine-protein phosphatase nonreceptor type 1                                                        PTPN1        1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)
  94   [P30279](https://www.uniprot.org/uniprot/P30279)   G1/S-specific cyclin-D2                                                                                CCND2        1        [Homosapiens](https://www.uniprot.org/taxonomy/9606)

[^1]: Academic Editor: Darren R. Williams
